These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 26845645)
1. miR-450b-5p Suppresses Stemness and the Development of Chemoresistance by Targeting SOX2 in Colorectal Cancer. Jin Y; Jiang Z; Guan X; Chen Y; Tang Q; Wang G; Wang X DNA Cell Biol; 2016 May; 35(5):249-56. PubMed ID: 26845645 [TBL] [Abstract][Full Text] [Related]
2. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1. Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050 [TBL] [Abstract][Full Text] [Related]
3. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis. Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942 [TBL] [Abstract][Full Text] [Related]
4. Overcoming stemness and chemoresistance in colorectal cancer through miR-195-5p-modulated inhibition of notch signaling. Jin Y; Wang M; Hu H; Huang Q; Chen Y; Wang G Int J Biol Macromol; 2018 Oct; 117():445-453. PubMed ID: 29852230 [TBL] [Abstract][Full Text] [Related]
5. miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression. Ye YP; Wu P; Gu CC; Deng DL; Jiao HL; Li TT; Wang SY; Wang YX; Xiao ZY; Wei WT; Chen YR; Qiu JF; Yang RW; Lin J; Liang L; Liao WT; Ding YQ Oncotarget; 2016 Sep; 7(38):61312-61324. PubMed ID: 27494869 [TBL] [Abstract][Full Text] [Related]
6. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer. Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904 [TBL] [Abstract][Full Text] [Related]
7. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells. Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-149 Increases the Sensitivity of Colorectal Cancer Cells to 5-Fluorouracil by Targeting Forkhead Box Transcription Factor FOXM1. Liu X; Xie T; Mao X; Xue L; Chu X; Chen L Cell Physiol Biochem; 2016; 39(2):617-29. PubMed ID: 27415661 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway. Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179 [TBL] [Abstract][Full Text] [Related]
10. miR-133b suppresses colorectal cancer cell stemness and chemoresistance by targeting methyltransferase DOT1L. Lv L; Li Q; Chen S; Zhang X; Tao X; Tang X; Wang S; Che G; Yu Y; He L Exp Cell Res; 2019 Dec; 385(1):111597. PubMed ID: 31525340 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-218 is a prognostic indicator in colorectal cancer and enhances 5-fluorouracil-induced apoptosis by targeting BIRC5. Li PL; Zhang X; Wang LL; Du LT; Yang YM; Li J; Wang CX Carcinogenesis; 2015 Dec; 36(12):1484-93. PubMed ID: 26442524 [TBL] [Abstract][Full Text] [Related]
12. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway. Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704 [TBL] [Abstract][Full Text] [Related]
13. Regulation of cancer stem cell properties, angiogenesis, and vasculogenic mimicry by miR-450a-5p/SOX2 axis in colorectal cancer. Chen J; Chen S; Zhuo L; Zhu Y; Zheng H Cell Death Dis; 2020 Mar; 11(3):173. PubMed ID: 32144236 [TBL] [Abstract][Full Text] [Related]
14. Elevated microRNA-23a Expression Enhances the Chemoresistance of Colorectal Cancer Cells with Microsatellite Instability to 5-Fluorouracil by Directly Targeting ABCF1. Li X; Li X; Liao D; Wang X; Wu Z; Nie J; Bai M; Fu X; Mei Q; Han W Curr Protein Pept Sci; 2015; 16(4):301-9. PubMed ID: 25929864 [TBL] [Abstract][Full Text] [Related]
15. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4. Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333 [TBL] [Abstract][Full Text] [Related]
16. Regulation of colorectal carcinoma stemness, growth, and metastasis by an miR-200c-Sox2-negative feedback loop mechanism. Lu YX; Yuan L; Xue XL; Zhou M; Liu Y; Zhang C; Li JP; Zheng L; Hong M; Li XN Clin Cancer Res; 2014 May; 20(10):2631-42. PubMed ID: 24658157 [TBL] [Abstract][Full Text] [Related]
17. miR-15b-5p resensitizes colon cancer cells to 5-fluorouracil by promoting apoptosis via the NF-κB/XIAP axis. Zhao C; Zhao Q; Zhang C; Wang G; Yao Y; Huang X; Zhan F; Zhu Y; Shi J; Chen J; Yan F; Zhang Y Sci Rep; 2017 Jun; 7(1):4194. PubMed ID: 28646148 [TBL] [Abstract][Full Text] [Related]
18. The SOX17/miR-371-5p/SOX2 axis inhibits EMT, stem cell properties and metastasis in colorectal cancer. Li Y; Lv Z; He G; Wang J; Zhang X; Lu G; Ren X; Wang F; Zhu X; Ding Y; Liao W; Ding Y; Liang L Oncotarget; 2015 Apr; 6(11):9099-112. PubMed ID: 25868860 [TBL] [Abstract][Full Text] [Related]
19. miR-106a Reduces 5-Fluorouracil (5-FU) Sensitivity of Colorectal Cancer by Targeting Dual-Specificity Phosphatases 2 (DUSP2). Qin Y; Chen X; Liu Z; Tian X; Huo Z Med Sci Monit; 2018 Jul; 24():4944-4951. PubMed ID: 30011263 [TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA ENST00000547547 reduces 5-fluorouracil resistance of colorectal cancer cells via competitive binding to microRNA-31. Li J; Li X; Cen C; Ai X; Lin C; Hu G Oncol Rep; 2018 Jan; 39(1):217-226. PubMed ID: 29115526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]